8-K: Graphjet Faces Nasdaq Delisting, Appeals Decision

Graphjet Technology has appealed Nasdaq's decision to delist its Class A ordinary shares and is seeking provisional relisting while preparing for its annual general meeting.

Summary

• Nasdaq delisted Graphjet Technology's Class A ordinary shares effective November 13, 2025, due to deficiencies in market value of listed securities and publicly held shares.
• The company appealed the delisting decision to the Nasdaq Listing and Hearing Review Council on November 25, 2025, and submitted a formal appeal with a compliance plan on December 10, 2025.
• Graphjet requested the Council to reverse the delisting and authorize provisional relisting during the appeal process.
• The company's Class A ordinary shares are currently trading on an over-the-counter market under the symbol GTIJF.
• An Annual General Meeting (AGM) is scheduled for December 19, 2025, where shareholders will vote on proposals integral to the compliance plan, including share issuances, an increase in authorized share capital, a warrant exercise proposal, director re-election, and ratification of the accounting firm.

Sentiment

Score: 3

Explanation: The delisting from Nasdaq is a significant negative event, indicating fundamental issues with market valuation and compliance. While the company is appealing and proposing a compliance plan, the outcome is uncertain, and the need for potential capital raises through share issuances suggests financial pressure. The move to OTC markets typically reduces investor confidence and liquidity.

Positives

• The company has submitted a formal appeal with an updated, documentation-backed compliance plan to the Nasdaq Listing and Hearing Review Council.
• The company is actively pursuing a provisional relisting on The Nasdaq Global Market during the pendency of the Council's review.
• Shareholders will vote on proposals at the AGM that are integral to the compliance plan, indicating proactive steps to address listing deficiencies.

Negatives

• Graphjet Technology's Class A ordinary shares were delisted from The Nasdaq Global Market effective November 13, 2025.
• The delisting was due to deficiencies under Nasdaq Listing Rules 5450(b)(2) (market value of listed securities) and 5450(b)(3)(C) (market value of publicly held shares).
• There is no assurance that the Nasdaq Listing and Hearing Review Council will grant the requested relief, that the company will regain or maintain compliance, or that the appeal will be successful.
• The company's shares are now quoted and trading on an over-the-counter market, which typically implies lower liquidity and visibility.

Risks

• No assurance that the Nasdaq Listing and Hearing Review Council will grant the requested relief (reversal of delisting or provisional relisting).
• No assurance that the company will regain or maintain compliance with Nasdaq Listing Rules.
• No assurance that the appeal will ultimately be successful.
• Actual results may differ from expectations, estimates, and projections due to various factors.
• Changes in the markets in which the company competes, including competitive landscape, technology evolution, or regulatory changes.
• Risk that the company will need to raise additional capital to execute its business plans, which may not be available on acceptable terms or at all.
• The company is beginning commercialization of its technology and it may not have an accurate estimate of future capital expenditures and future revenue.
• Uncertainty regarding the company's ability to develop and manufacture its graphene and graphite products.
• Uncertainty regarding the company's ability to return to and maintain compliance with Nasdaq continued listing standards.

Future Outlook

The company is actively pursuing an appeal of its Nasdaq delisting, seeking a reversal of the decision and provisional relisting. It plans to implement a compliance plan, which includes shareholder approval for share issuances and an increase in authorized share capital, to regain and maintain compliance with Nasdaq listing standards. However, there is no assurance that the appeal will be successful or that the company will achieve its compliance goals.

Industry Context

This announcement primarily concerns a company-specific regulatory compliance issue rather than broader industry trends. The delisting from a major exchange like Nasdaq and subsequent trading on an over-the-counter market can impact investor perception and access to capital, potentially setting a cautionary precedent for other emerging growth companies struggling with listing requirements.

Corporate Governance

Legal Proceedings

• The company is involved in an appeal process with the Nasdaq Listing and Hearing Review Council regarding the delisting of its Class A ordinary shares (Docket No. NQ 7187N-25).

Stakeholder Impact

• Shareholders face potential dilution from proposed share issuances and an increase in authorized share capital.
• Shareholders are impacted by the delisting from Nasdaq, which typically leads to reduced liquidity and visibility for their shares, now trading on an over-the-counter market.
• Shareholders are required to vote on critical proposals at the AGM that are integral to the company's compliance plan and future operations.

Next Steps

• The Nasdaq Listing and Hearing Review Council will review the company's appeal and compliance plan.
• The Annual General Meeting of shareholders will be held on December 19, 2025, to vote on key proposals.
• The company will continue efforts to regain and maintain compliance with Nasdaq Listing Rules.

Key Dates

Recommendation

The delisting from Nasdaq due to market value deficiencies is a severe negative signal, indicating fundamental issues with the company's valuation and investor confidence. While an appeal is underway, the outcome is uncertain, and the move to an over-the-counter market significantly reduces liquidity and visibility. The need for shareholder approval for share issuances and an increase in authorized capital strongly suggests an impending capital raise, which will likely result in significant dilution for existing shareholders. Given these substantial risks and the current trading environment, a strong sell recommendation is warranted for investors to mitigate further potential losses.

Keywords

Graphjet Technology, Nasdaq delisting, SEC filing, Form 8-K, stock market, over-the-counter, corporate governance, shareholder meeting, compliance plan, capital raise, graphene, graphite